In utero stem cell therapy for spina bifida found safe in early trial
The use of stem cell patches to treat fetuses with spina bifida has been shown to be safe following a phase 1 clinical trial...
The unborn offspring of a mammal. In humans, this stage of development lasts from nine weeks after fertilisation until birth.
The use of stem cell patches to treat fetuses with spina bifida has been shown to be safe following a phase 1 clinical trial...
by Iona Aylwin
A new approach to high-chance prenatal Down's syndrome screening, involving AI, could improve the predictive accuracy of the 'combined' test for Down's syndrome...
Following reports that UK patients are seeking PGT-P – a form of preimplantation genetic testing that involves polygenic scores – Professor Angus Clarke discusses problems with polygenic scores in general, and with PGT-P in particular...
Speakers highlighted the need for interdisciplinary dialogue between ethicists and researchers when considering ethical research involving stem cell-based-embryo models...
by BioNews
Professor of stem cell science, Dusko Ilic, discusses concerns raised by the plans of a US-based startup – the (new) Manhattan Project – to create genome-edited babies…
A previously unknown function of platelets to 'hoover up' and store DNA in the blood could improve cancer diagnosis and prenatal screening...
by Jen Willows
The portions of a mother's genome that influence a child's weight can include genes not inherited by the child, according to new research...
Organoids comprising brain and blood vessel cells have been generated from human pluripotent stem cells, yielding a composition of different cell types similar to that of a 40-day-old fetus...
Genome editing administered to fetal mice has corrected the mutation causing cystic fibrosis before birth...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.